Bayer Returns a $332 Million Verdict in a Roundup Trial
Recently, a jury found the company Bayer liable in a product liability lawsuit brought by plaintiff Mike Dennis who alleged his non-Hodgkin lymphoma was the result of exposure to Bayer’s Roundup weed killer. The jury ordered Bayer to pay $332 million in damages, of which $7 million is in compensatory damages and $325 million is in punitive damages. If you developed cancer and believe it was caused by exposure to Bayer’s Roundup, call the experienced Chicago-based lawyers of Moll Law Group. We represent clients nationwide.
Call Moll Law Group About Your Weed Killer Claim
The $332 million damages verdict was the third trial loss for Bayer this month. The prior verdicts in Roundup trials were $175 million and $1.25 million. However, these wins for the plaintiffs came after a string of nine consecutive trials with similar claims. In 2020, Bayer settled most of the Roundup claims against it for up to $10.9 billion. Around 40,000 Roundup-related cases are still in process against it.
With regard to this verdict, the jury agreed with Bayer in connection with two out of four legal claims. It found that the company failed to warn of Roundup’s risks, but that it was not negligent, and that the product was not defectively designed.
Illinois Injury and Mass Tort Lawyer Blog





Manufacturer Medline Industries initiated a
Manufacturer Kraft Heinz discovered that one of the machines that individually wraps Kraft Singles American processed cheese slices permits thin strips of film to say on the slices even after removal of the wrapper. The food company announced a
The Food and Drug Administration recently updated the
Bard’s PowerPort devices are implanted under the skin and pump intravenous chemotherapy and other fluid into a patient’s bloodstream. These are two-part devices with an injection reservoir and a catheter. Recently, plaintiffs in eight lawsuits against Becton, Dickinson & Company, C.R. Bard, Inc., and Bard Access Systems
Phenylephrine is an ingredient in popular oral decongestants branded as Vicks Nyquil Sinex Nighttime Sinus Relief, Sudafed PE, and Benadryl Allergy Plus Congestion. It was believed that the drug worked to reduce blood vessel swelling in the nasal passages, and that this got rid of congestion. These decongestants generated nearly $1.8 billion in sales in 2022. A Food and Drug Administration (FDA)
The Carina Sub-Acute Care Ventilator was recently
The new feature length documentary “
The manufacturer Hamilton Medical Inc. has 